- Home
- NRXP vs BNR Comparison
NRXP vs BNR Comparison
Compare NRXP & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXP
- BNR
- Stock Information
- Founded
- NRXP 2015
- BNR 2014
- Country
- NRXP United States
- BNR China
- Employees
- NRXP N/A
- BNR N/A
- Industry
- NRXP Biotechnology: Pharmaceutical Preparations
- BNR Medical Specialities
- Sector
- NRXP Health Care
- BNR Health Care
- Exchange
- NRXP Nasdaq
- BNR Nasdaq
- Market Cap
- NRXP 32.6M
- BNR 29.1M
- IPO Year
- NRXP N/A
- BNR 2020
- Fundamental
- Price
- NRXP $2.24
- BNR $2.62
- Analyst Decision
- NRXP Strong Buy
- BNR
- Analyst Count
- NRXP 4
- BNR 0
- Target Price
- NRXP $28.50
- BNR N/A
- AVG Volume (30 Days)
- NRXP 184.4K
- BNR 54.8K
- Earning Date
- NRXP 05-15-2025
- BNR 05-28-2025
- Dividend Yield
- NRXP N/A
- BNR N/A
- EPS Growth
- NRXP N/A
- BNR N/A
- EPS
- NRXP N/A
- BNR N/A
- Revenue
- NRXP N/A
- BNR $70,669,261.00
- Revenue This Year
- NRXP N/A
- BNR $136.32
- Revenue Next Year
- NRXP N/A
- BNR N/A
- P/E Ratio
- NRXP N/A
- BNR N/A
- Revenue Growth
- NRXP N/A
- BNR N/A
- 52 Week Low
- NRXP $1.10
- BNR $2.18
- 52 Week High
- NRXP $6.01
- BNR $8.99
- Technical
- Relative Strength Index (RSI)
- NRXP 60.34
- BNR 25.59
- Support Level
- NRXP $1.97
- BNR $2.30
- Resistance Level
- NRXP $2.35
- BNR $2.71
- Average True Range (ATR)
- NRXP 0.12
- BNR 0.25
- MACD
- NRXP 0.03
- BNR 0.05
- Stochastic Oscillator
- NRXP 75.28
- BNR 8.00
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.